Overview

Digoxin Induced Dissolution of CTC Clusters

Status:
Recruiting

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

This single arm therapeutic exploratory study of digoxin in patients with advanced or metastatic breast cancer investigates whether cardiac glycosides are able to disrupt CTC clusters in breast cancer patients.

Phase:

Early Phase 1

Details

Lead Sponsor:

University Hospital, Basel, Switzerland

Treatments:

Digoxin